Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

More than one HMG-CoA lyase: the classical mitochondrial enzyme plus the peroxisomal and the cytosolic ones

  • Arnedo, María
  • Latorre-Pellicer, Ana
  • Lucia-Campos, Cristina
  • Gil-Salvador, Marta
  • Antoñanzas-Peréz, Rebeca
  • Gómez-Puertas, Paulino
  • Bueno-Lozano, Gloria
  • Puisac, Beatriz
  • Pié, Juan
There are three human enzymes with HMG-CoA lyase activity that are able to synthesize ketone bodies in different subcellular compartments. The mitochondrial HMG-CoA lyase was the first to be described, and catalyzes the cleavage of 3-hydroxy-3-methylglutaryl CoA to acetoacetate and acetyl-CoA, the common final step in ketogenesis and leucine catabolism. This protein is mainly expressed in the liver and its function is metabolic, since it produces ketone bodies as energetic fuels when glucose levels are low. Another isoform is encoded by the same gene for the mitochondrial HMG-CoA lyase (HMGCL), but it is located in peroxisomes. The last HMG-CoA lyase to be described is encoded by a different gene, HMGCLL1, and is located in the cytosolic side of the endoplasmic reticulum membrane. Some activity assays and tissue distribution of this enzyme have shown the brain and lung as key tissues for studying its function. Although the roles of the peroxisomal and cytosolic HMG-CoA lyases remain unknown, recent studies highlight the role of ketone bodies in metabolic remodeling, homeostasis, and signaling, providing new insights into the molecular and cellular function of these enzymes., This work was supported by: Diputación General de Aragón-FEDER: European Social Fund (Grupo de Referencia B32_17R, to Juan Pié.), as well as grants from the Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación RTC-2017-6494-1 and RTI2018-094434-B-I00 (MCIU/AEI/FEDER, UE) to Paulino Gómez-Puertas. Beatriz Puisac and Juan Pié are members of CIBERER-GCV02 and María Arnedo, Ana Latorre-Pellicer, Cristina Lucia-Campos, Marta Gil-Salvador, Rebeca Antoñanzas-Peréz, Beatriz Puisac and Juan Pié are members of ISS-Aragon at the School of Medicine, University of Zaragoza., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Molecular characterization of Tc964, a novel antigenic protein from trypanosoma cruzi

  • Ruiz-Márvez, Elizabeth
  • Ramírez, César Augusto
  • Rodríguez, Eliana Rocío
  • Flórez, Magda Mellisa
  • Delgado, Gabriela
  • Guzmán, Fanny
  • Gómez-Puertas, Paulino
  • Requena, José María
  • Puerta, Concepción J.
The Tc964 protein was initially identified by its presence in the interactome associated with the LYT1 mRNAs, which code for a virulence factor of Trypanosoma cruzi. Tc964 is annotated in the T. cruzi genome as a hypothetical protein. According to phylogenetic analysis, the protein is conserved in the different genera of the Trypanosomatidae family; however, recognizable orthologues were not identified in other groups of organisms. Therefore, as a first step, an in-depth molecular characterization of the Tc946 protein was carried out. Based on structural predictions and molecular dynamics studies, the Tc964 protein would belong to a particular class of GTPases. Subcellular fractionation analysis indicated that Tc964 is a nucleocytoplasmic protein. Additionally, the protein was expressed as a recombinant protein in order to analyze its antigenicity with sera from Chagas disease (CD) patients. Tc964 was found to be antigenic, and B-cell epitopes were mapped by the use of synthetic peptides. In parallel, the Leishmania major homologue (Lm964) was also expressed as recombinant protein and used for a preliminary evaluation of antigen cross-reactivity in CD patients. Interestingly, Tc964 was recognized by sera from Chronic CD (CCD) patients at different stages of disease severity, but no reactivity against this protein was observed when sera from Colombian patients with cutaneous leishmaniasis were analyzed. Therefore, Tc964 would be adequate for CD diagnosis in areas where both infections (CD and leishmaniasis) coexist, even though additional assays using larger collections of sera are needed in order to confirm its usefulness for differential serodiagnosis., This research was funded by Ministerio de Ciencia, Tecnología e Innovación (Minciencias) and Pontificia Universidad Javeriana, research project ID PPTA 120356933228 granted to C.J.P. The article publication was funded by the Vicerrectoría de Investigación from the Pontificia Universidad Javeriana, code 120813F0401200. The Network of Tropical Diseases Research RICET (RD16/0027/0008, Instituto de Salud Carlos III and co-funded by FEDER) to J.M.R., and grants from the Spanish Ministerio de Ciencia, Innovación y Universidades/Agencia Estatal de Investigación RTC-2017-6494-1 and RTI2018-094434-B-I00 (MCIU/AEI/FEDER, UE) to P.G.-P., E.R.-M and E.R.R. were supported by Minciencias convocatoria doctorados nacionales 647-2014 and convocatoria jóvenes investigadores e innovadores 706-2015, respectively., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel dominant KCNQ2 exon 7 partial in-frame duplication in a complex epileptic and neurodevelopmental delay syndrome

  • Lazo, Pedro A.
  • García, Juan L.
  • Gómez-Puertas, Paulino
  • Marcos-Alcalde, Íñigo
  • Arjona, César
  • Villarroel, Álvaro
  • González-Sarmiento, Rogelio
  • Fons, Carmen
Complex neurodevelopmental syndromes frequently have an unknown etiology, in which genetic factors play a pathogenic role. This study utilizes whole-exome sequencing (WES) to examine four members of a family with a son presenting, since birth, with epileptic-like crises, combined with cerebral palsy, severe neuromotor and developmental delay, dystonic tetraparexia, axonal motor affectation, and hyper-excitability of unknown origin. The WES study detected within the patient a de novo heterozygous in-frame duplication of thirty-six nucleotides within exon 7 of the human KCNQ2 gene. This insertion duplicates the first twelve amino acids of the calmodulin binding site I. Molecular dynamics simulations of this KCNQ2 peptide duplication, modelled on the 3D structure of the KCNQ2 protein, suggest that the duplication may lead to the dysregulation of calcium inhibition of this protein function., Grants from Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (SAF2016-75744-R, PID2019-105610RB-I00) and Consejería de Educación-Junta de Castilla y León (CLC-2017-01 and UIC-258) to P.A.L. Ministerio de Economía, Industria y Competitividad (CTQ2015-68756-R, BFU2015-66910-R) to A.V. Ministerio de Economía y Competitividad-Fondo Social Europeo Grant from Instituto de Salud Carlos III-Fondo Social Europeo (PI16/01920) to R. G-S. Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (RTC-2017-6494-1 and RTI2018-094434-B-I00) to P. G-P. Financial support of the Departament de Salut de la Generalitat de Catalunya-URDCat Project (SLT002/16/00174) to C.A. and C.F., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

VRK1 (Y213H) homozygous mutant impairs Cajal bodies in a hereditary case of distal motor neuropathy

  • Marcos, Ana T.
  • Martín-Doncel, Elena
  • Morejón-García, Patricia
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Segura‐Puimedon, María
  • Armengol, Lluís
  • Navarro‐Pando, José M.
  • Lazo, Pedro A.
[Background]: Distal motor neuropathies with a genetic origin have a heterogeneous clinical presentation with overlapping features affecting distal nerves and including spinal muscular atrophies and amyotrophic lateral sclerosis. This indicates that their genetic background is heterogeneous., [Patient and methods]: In this work, we have identified and characterized the genetic and molecular base of a patient with a distal sensorimotor neuropathy of unknown origin. For this study, we performed whole‐exome sequencing, molecular modelling, cloning and expression of mutant gene, and biochemical and cell biology analysis of the mutant protein., [Results]: A novel homozygous recessive mutation in the human VRK1 gene, coding for a chromatin kinase, causing a substitution (c.637T > C; p.Tyr213His) in exon 8, was detected in a patient presenting since childhood a progressive distal sensorimotor neuropathy and spinal muscular atrophy syndrome, with normal intellectual development. Molecular modelling predicted this mutant VRK1 has altered the kinase activation loop by disrupting its interaction with the C‐terminal regulatory region. The p.Y213H mutant protein has a reduced kinase activity with different substrates, including histones H3 and H2AX, proteins involved in DNA damage responses, such as p53 and 53BP1, and coilin, the scaffold for Cajal bodies. The mutant VRK1(Y213H) protein is unable to rescue the formation of Cajal bodies assembled on coilin, in the absence of wild‐type VRK1., [Conclusion]: The VRK1(Y213H) mutant protein alters the activation loop, impairs the kinase activity of VRK1 causing a functional insufficiency that impairs the formation of Cajal bodies assembled on coilin, a protein that regulates SMN1 and Cajal body formation., E. M‐D., and P. M‐G. were supported by Junta de Castilla y León‐Fondo Social Europeo (ESF), and Ministerio de Educación‐FPU predoctoral (FPU16/01883) fellowships, respectively. This work was funded by grants from Ministerio de Ciencia, Innovación y Universidades‐Agencia Estatal de Investigación (SAF2016‐75744‐R, RED2018‐102801‐T) and Consejería de Educación‐Junta de Castilla y León‐ERDF (UIC‐258) to P.A.L. Ministerio de Ciencia, Innovación y Universidades‐Agencia Estatal de Investigación (RTC‐2017‐6494‐1 and RTI2018‐094434‐B‐I00) and European Commission project "CONNECT‐JPIAMR” Virtual Research Institute to P.G‐P. The Instituto de Biología Molecular y Celular del Cáncer is cofunded by Junta de Castilla y León‐European Regional Development Fund (CLC–2017–01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathogenic convergence of CNVs in genes functionally associated to a severe neuromotor developmental delay syndrome

  • García-Hernández, Juan L.
  • Corchete, Luis A.
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Fons, Carmen
  • Lazo, Pedro A.
© The Author(s)., [Background]: Complex developmental encephalopathy syndromes might be the consequence of unknown genetic alterations that are likely to contribute to the full neurological phenotype as a consequence of pathogenic gene combinations. [Methods]: To identify the additional genetic contribution to the neurological phenotype, we studied as a test case a boy, with a KCNQ2 exon-7 partial duplication, by single-nucleotide polymorphism (SNP) microarray to detect copy-number variations (CNVs). [Results]: The proband presented a cerebral palsy like syndrome with a severe motor and developmental encephalopathy. The SNP array analysis detected in the proband several de novo CNVs, nine partial gene losses (LRRC55, PCDH9, NALCN, RYR3, ELAVL2, CDH13, ATP1A2, SLC17A5, ANO3), and two partial gene duplications (PCDH19, EFNA5). The biological functions of these genes are associated with ion channels such as calcium, chloride, sodium, and potassium with several membrane proteins implicated in neural cell-cell interactions, synaptic transmission, and axon guidance. Pathogenically, these functions can be associated to cerebral palsy, seizures, dystonia, epileptic crisis, and motor neuron dysfunction, all present in the patient. [Conclusions]: Severe motor and developmental encephalopathy syndromes of unknown origin can be the result of a phenotypic convergence by combination of several genetic alterations in genes whose physiological function contributes to the neurological pathogenic mechanism., Grants from Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación (SAF2016-75744-R, PID2019-105610RB-I00) and Consejería de Educación-Junta de Castilla y León (CSI264P20, CLC-2017-01, and UIC-258) to P.A.L. Agencia Estatal de Investigación-Ministerio de Economía y Competitividad-FEDER-Fondo Social Europeo (RTC-2017-6494-1 and RTI2018-094434-B-I00) to P. G-P. Departament de Salut de la Generalitat de Catalunya-URDCat Project (SLT002/16/00174) to C.F.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pathogenic effects of Leu200Pro and Arg387His VRK1 protein variants on phosphorylation targets and H4K16 acetylation in distal hereditary motor neuropathy

  • Campos Díaz, Aurora
  • Morejón-García, Patricia
  • Monte-Serrano, Eva
  • Ros-Pardo, David
  • Marcos-Alcalde, Íñigo
  • Gómez-Puertas, Paulino
  • Lazo, Pedro A.
Rare recessive variants in the human VRK1 gene are associated with several motor neuron diseases (MND), such as amyotrophic lateral sclerosis, spinal muscular atrophy, or distal hereditary motor neuropathies (dHMN). A case with dHMN carrying two novel VRK1 gene variants, expressing Leu200Pro (L200P) and Arg387His (R387H) variant proteins, identified that these protein variants are functionally different. The Leu200Pro variant shares with several variants in the catalytic domain the loss of the kinase activity on different substrates, such as histones, p53, or coilin. However, the distal Arg387His variant and the distal Trp375* (W375X) chinese variant, both located at the end of the low complexity C-terminal region and proximal to the termination codon, retain their catalytic activity on some substrates, and mechanistically their functional impairment is different. The L200P variant, as well as most VRK1 pathogenic variants, impairs the phosphorylation of BAF and histone H4K16 acetylation, which are required for DNA attachment to the nuclear envelope and chromatin accessibility to DNA repair mechanisms, respectively. The R387H variant impairs phosphorylation of H2AX, an early step in different types of DNA damage responses. The functional variability of VRK1 protein variants and their different combinations are a likely contributor to the clinical phenotypic heterogeneity of motor neuron and neurological diseases associated with rare VRK1 pathogenic variants., Agencia Estatal de Investigación, PID2019-105610RB-I00, Pedro A. Lazo, PID2022-139598OB-I00, Pedro A. Lazo, RED2018-102801-T, Pedro A. Lazo, RTC-2017-6494-1, Paulino Gómez-Puertas, RTI2018-094434-B-I00, Paulino Gómez-Puertas, Consejería de Educación, Junta de Castilla y León, CSI264P20, Pedro A. Lazo,CLC-2017-01, Pedro A. Lazo, CSI004-18, Eva Monte-Serrano, European JPIAMR network “EPIC-Alliance, Ministerio de Universidades, FPU20/02978, Aurora Campos-Díaz, FPU16/01883, Patricia Morejón-García., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Reseña (Review)

More than one HMG-CoA Lyase: The classical mitochondrial enzyme plus the peroxisomal and the cytosolic ones

  • Arnedo, María
  • Latorre-Pellicer, Ana
  • Lucia-Campos, Cristina
  • Gil-Salvador, Marta
  • Antoñanzas-Peréz, Rebeca
  • Gómez-Puertas, Paulino
  • Bueno-Lozano, Gloria
  • Puisac, Beatriz
  • Pié, Juan
There are three human enzymes with HMG-CoA lyase activity that are able to synthesize ketone bodies in different subcellular compartments. The mitochondrial HMG-CoA lyase was the first to be described, and catalyzes the cleavage of 3-hydroxy-3-methylglutaryl CoA to acetoacetate and acetyl-CoA, the common final step in ketogenesis and leucine catabolism. This protein is mainly expressed in the liver and its function is metabolic, since it produces ketone bodies as energetic fuels when glucose levels are low. Another isoform is encoded by the same gene for the mitochondrial HMG-CoA lyase (HMGCL), but it is located in peroxisomes. The last HMG-CoA lyase to be described is encoded by a different gene, HMGCLL1, and is located in the cytosolic side of the endoplasmic reticulum membrane. Some activity assays and tissue distribution of this enzyme have shown the brain and lung as key tissues for studying its function. Although the roles of the peroxisomal and cytosolic HMG-CoA lyases remain unknown, recent studies highlight the role of ketone bodies in metabolic remodeling, homeostasis, and signaling, providing new insights into the molecular and cellular function of these enzymes.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Evaluating Face2Gene as a Tool to Identify Cornelia de Lange Syndrome by Facial Phenotypes

  • Latorre-Pellicer, Ana
  • Ascaso, Ángela
  • Trujillano, Laura
  • Gil-Salvador, Marta
  • Arnedo, María
  • Lucia-Campos, Cristina
  • Antoñanzas-Pérez, Rebeca
  • Marcos-Alcalde, Iñigo
  • Parenti, Ilaria
  • Bueno-Lozano, Gloria
  • Musio, Antonio
  • Puisac, Beatriz
  • Kaiser, Frank J.
  • Ramos, Feliciano J.
  • Gómez-Puertas, Paulino
  • Pié, Juan
Characteristic or classic phenotype of Cornelia de Lange syndrome (CdLS) is associated with a recognisable facial pattern. However, the heterogeneity in causal genes and the presence of overlapping syndromes have made it increasingly difficult to diagnose only by clinical features. DeepGestalt technology, and its app Face2Gene, is having a growing impact on the diagnosis and management of genetic diseases by analysing the features of affected individuals. Here, we performed a phenotypic study on a cohort of 49 individuals harbouring causative variants in known CdLS genes in order to evaluate Face2Gene utility and sensitivity in the clinical diagnosis of CdLS. Based on the profile images of patients, a diagnosis of CdLS was within the top five predicted syndromes for 97.9% of our cases and even listed as first prediction for 83.7%. The age of patients did not seem to affect the prediction accuracy, whereas our results indicate a correlation between the clinical score and affected genes. Furthermore, each gene presents a different pattern recognition that may be used to develop new neural networks with the goal of separating different genetic subtypes in CdLS. Overall, we conclude that computer-assisted image analysis based on deep learning could support the clinical diagnosis of CdLS
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Delineation of phenotypes and genotypes related to cohesin structural protein RAD21

  • Krab, L.C.
  • Marcos-Alcalde, I.
  • Assaf, M.
  • Balasubramanian, M.
  • Andersen, J.B.
  • Bisgaard, A.M.
  • Fitzpatrick, D.R.
  • Gudmundsson, S.
  • Huisman, S.A.
  • Kalayci, T.
  • Maas, S.M.
  • Martinez, F.
  • McKee, S.
  • Menke, L.A.
  • Mulder, P.A.
  • Murch, O.D.
  • Parker, M.
  • Pie, J.
  • Ramos, F.J.
  • Rieubland, C.
  • Mokry, J.A.R.
  • Scarano, E.
  • Shinawi, M.
  • Gomez-Puertas, P.
  • Tumer, Z.
  • Hennekam, R.C.
RAD21 encodes a key component of the cohesin complex, and variants in RAD21 have been associated with Cornelia de Lange Syndrome (CdLS). Limited information on phenotypes attributable to RAD21 variants and genotype-phenotype relationships is currently published. We gathered a series of 49 individuals from 33 families with RAD21 alterations [24 different intragenic sequence variants (2 recurrent), 7 unique microdeletions], including 24 hitherto unpublished cases. We evaluated consequences of 12 intragenic variants by protein modelling and molecular dynamic studies. Full clinical information was available for 29 individuals. Their phenotype is an attenuated CdLS phenotype compared to that caused by variants in NIPBL or SMC1A for facial morphology, limb anomalies, and especially for cognition and behavior. In the 20 individuals with limited clinical information, additional phenotypes include Mungan syndrome (in patients with biallelic variants) and holoprosencephaly, with or without CdLS characteristics. We describe several additional cases with phenotypes including sclerocornea, in which involvement of the RAD21 variant is uncertain. Variants were frequently familial, and genotype-phenotype analyses demonstrated striking interfamilial and intrafamilial variability. Careful phenotyping is essential in interpreting consequences of RAD21 variants, and protein modeling and dynamics can be helpful in determining pathogenicity. The current study should be helpful when counseling families with a RAD21 variation.